Munich, 30th November 2022, Insempra, a biology-powered company enabling businesses to make superior products with nature, today announces its new collaboration with the BioInnovation Institute (BII) to accelerate and support biotech innovation.
The collaboration between Insempra and the BioInnovation Institute (BII) will help identify early-stage innovation and technology to advance the development of sustainable solutions for the benefit of people, society and the planet.
Insempra will support the collaboration by mentoring BII portfolio companies and advising early-stage startups within the synthetic biology space. BII will open their network of investors and stakeholders to Insempra, which will help accelerate scouting new technologies to support the company’s mission to develop superior ingredients for wide-scale market application.
“We are honored to be one of the BII’s few selected industry collaborators and look forward to the new opportunities this collaboration will bring to advance innovation within our field. By advising and mentoring BII’s early-stage portfolio companies, we will have the opportunity to start a dialogue with some of the most exciting innovators working towards the same vision as Insempra to drive the regenerative revolution for a better future.” Jens Klein, CEO and Founder of Insempra comments.
Insempra and its team of experienced biologists, entrepreneurs and commercial experts has extensive knowledge in scaling and commercializing biotech and will share this knowledge with BII portfolio companies throughout the collaboration to facilitate joint action for a more sustainable future.
“The collaboration between BII and Insempra is founded on a mutual vision for a sustainable future. With BII’s strategic focus as a non-profit foundation supporting early-stage start-ups that improve planetary health and Insempra’s mission to manufacture at scale in collaboration with nature, we look forward to the synergies we can create and the value this collaboration can bring.” Senior Business Developer at BII, Christian Brix Tillegreen, added.
Insempra is a biology-powered company enabling businesses to make superior products with nature. We combine bioscience and technology to grow matter for new and better products.
For too long, businesses have relied on chemical industrialization processes and petrochemicals, depleting our planet’s limited resources. That’s why we are committed to driving the regenerative revolution to manufacture at scale in collaboration with nature.
Led by a hand-picked team of biologists, technologists and entrepreneurs with rebel hearts, Insempra is here to create a new school of thought and collective action. The time to restore the balance between people and the planet is now. We don’t wait for change. We do what needs to be done to grow a better future.
About BioInnovation Institute
The BioInnovation Institute Foundation (BII) is an international commercial foundation with a non-profit objective. BII operates an incubator to accelerate world-class life science innovation.
Our vision is to support world-class life science innovation that drives the development of new solutions by early life science start-ups for the benefit of people and society.
With continued positive development, The Novo Nordisk Foundation can provide up to EUR 470 (3,5 mia. DKK) to BII over 10 years.
Learn more about BII at bii.dk
Ann Bartling / Michael Trace
Tel: +44/(0)20/3727 1000